Opendata, web and dolomites

Secreters SIGNED

A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Secreters project word cloud

Explore the words cloud of the Secreters project. It provides you a very rough idea of what is the project "Secreters" about.

proteins    medicines    format    responsible    pastoris    recombinant    powerful    entrepreneurial    beneficiaries    producing    critical    industry    skills    categories    partnership    billion    escherichia    pose    redox    daily    bonded    foci    intersectoral    yeast    difficult    premier    interdisciplinary    scientists    enzymes    pichia    140    enzyme    capitalises    thrive    biotherapeutic    innovations    combined    world    synthetic    15    industrial    life    disulphide    team    academic    lower    coli    super    esrs    generation    biology    expertise    expression    express    biotherapeutics    companies    severe    protein    treatment    biotechnology    engage    commitment    equip    patient    permeate    markets    assurance    ranging    bacillus    innovation    drugs    industries    microbial    clear    poised    outreach    series    chemistry    secreters    hosts    sectors    train    species    excess    close    ing    quality    diseases    trained    former    latter    whereas    training    superbly   

Project "Secreters" data sheet

The following table provides information about the project.

Coordinator
ACADEMISCH ZIEKENHUIS GRONINGEN 

Organization address
address: HANZEPLEIN 1
city: GRONINGEN
postcode: 9713 GZ
website: www.umcg.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 4˙087˙420 €
 EC max contribution 4˙087˙420 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACADEMISCH ZIEKENHUIS GRONINGEN NL (GRONINGEN) coordinator 531˙239.00
2    UNIVERSITY OF KENT UK (CANTERBURY, KENT) participant 606˙345.00
3    OULUN YLIOPISTO FI (OULU) participant 561˙611.00
4    ACIB GMBH AT (GRAZ) participant 528˙414.00
5    CELLTECH R&D LIMITED UK (SLOUGH) participant 303˙172.00
6    LONZA AG CH (BASEL) participant 281˙276.00
7    BOEHRINGER INGELHEIM RCV GMBH & CO KG AT (WIEN) participant 264˙207.00
8    AB Enzymes GmbH DE (Darmstadt) participant 252˙788.00
9    HUMBOLDT-UNIVERSITAET ZU BERLIN DE (BERLIN) participant 252˙788.00
10    UNIVERSITAET GREIFSWALD DE (GREIFSWALD) participant 252˙788.00
11    UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS DE (GREIFSWALD) participant 252˙788.00
12    UCB PHARMA SA BE (BRUXELLES) participant 0.00
13    BIOMIN HOLDING GMBH AT (GETZERSDORF BEI TRAISMAUER) partner 0.00
14    Gedeon Richter Plc. HU (Budapest) partner 0.00
15    POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH AT (KLOSTERNEUBURG) partner 0.00
16    UNIVERSITAET FUER BODENKULTUR WIEN AT (WIEN) partner 0.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

The ‘SECRETERS’ partnership aims to bring about a step change in the production of recombinant proteins, particularly Biotherapeutics and Industrial Enzymes. Both are critical products for the EU biotechnology sector, with combined markets in excess of $140 billion p.a.; the former are essential for the treatment of major diseases whereas the latter permeate every aspect of our daily life. Many proteins in these categories pose severe problems in production, especially disulphide-bonded proteins and new format 'difficult-to-express' proteins. SECRETERS will train a team of 15 ESRs to develop a new generation of super-producing microbial production hosts, including Escherichia coli, Bacillus species and the yeast Pichia pastoris. The project capitalises on a series of recent innovations and involves close collaboration between 5 academic Beneficiaries, who provide world-leading expertise in redox chemistry, synthetic biology and protein expression, and 5 non-academic Beneficiaries, who include some of the world's premier biotherapeutic and industrial enzyme companies. It will enable the biotherapeutics industry to produce challenging medicines at lower costs, resulting in new drugs and wider patient access, and allow the enzymes industry to deliver a range of powerful new products. SECRETERS will equip ESRs with the interdisciplinary and intersectoral skills required to thrive in these industries, with quality assurance systems embedded throughout the programme and a commitment to a wide-ranging dissemination/outreach programme. Based on a responsible innovation approach, with clear foci on research and entrepreneurial training, SECRETERS will deliver a team of superbly-trained scientists, poised to engage in some of Europe's most important biotechnology sectors.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SECRETERS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SECRETERS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

NL4XAI (2019)

Interactive Natural Language Technology for Explainable Artificial Intelligence

Read More  

Shape-IT (2019)

Supporting the interaction of Humans and Automated vehicles: Preparing for the EnvIronment of Tomorrow

Read More  

EVIDENCE (2020)

Erythrocytes properties and viability in dependence of flow and extra-cellular environment

Read More